EXCLUSIVE: Pfizer Prepares Data for FDA Approval of COVID-19 mRNA 'Vaccines' in Healthy Adults

Recent FDA departures indicate that the reason Pfizer ended patient enrollment in their COVID-19 mRNA trial is that ‘placebo-controlled clinical trials are no longer needed’ for FDA approval.

May 23, 2026: According to REUTERS, Pfizer closed enrollment in their COVID-19 mRNA injection trial for healthy adults aged 50-64, on March 6, 2026, in a letter dated March 30.

While the mainstream and alternative media reported reason for Pfizer ending patient recruitment was that, "enrollment in the trials had been too low to generate the needed data” —

Recent FDA Actions Indicate Placebo-Controlled Trials are NO Longer Required for FDA Approval of mRNA Boosters or New mRNA ‘Vaccines’

— Recent FDA actions indicate that the reasonPfizer ended patient enrollment in their COVID-19 mRNA trial is that ‘placebo-controlled clinical trials are no longer needed’ for FDA approval in healthy adults.

The FDA’s 2025 Background History on New Clinical Trials for Vaccines

In May of 2025, former head of CBER and FDA Vaccine Chief - Dr. Vinay Prasad - in partnership with former FDA Commissioner - Dr. Marty Makary - announced that, “The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to older adults and those at risk of developing severe illness.”

The FDA Dares to Require Human Studies for Vaccines Used in Humans

The new FDA requirements by Prasad and Makary, included comparing the COVID-19 mRNA boosters to a placebo-controlled arm in healthy adults - not mice.

Prasad’s and Makary’s 2025 attempt to restore human safety and efficacy standards for vaccines were likely not welcomed by Pfizer, Moderna or the entire BioPharma industrial complex, as they were previously able to obtain annual booster approval based on antibody measurements in mice.

Vinay Prasad Leaves the FDA in July of 2025 - Prasad Returns in August of 2025

Dr. Prasad’s reinforcement of previously well-established safety protocols for FDA-approved biologics may have attributed to his abrupt departure on July 30, 2025.

Inexplicably - Prasad returned 2 weeks later on August 9, 2025, according to Politico.

Pfizer Stops Clinical Trial Enrollment on March 6, 2026 - the Same Day Prasad Leaves the FDA - AGAIN

Per REUTERS, “Two sources from companies that manage 18 of the 208 trial sites, said Pfizer told them in writing in early March to stop recruitment.” - (March 6th to be exact.)

Politico reported that on March 6, 2025, “Vinay Prasad, the Trump administration regulator who angered pharma companies and crushed the hopes of patients with rare diseases with a series of controversial decisions to reject new drug applications, will leave the agency next month.”

This was his second departure from CBER.

Pfizer’s FDA Submission for COVID mRNA ‘Vaccines’ in Healthy Adults Will NOT Be Based on COVID-19 Infection Rates or Symptoms

REUTERS reported that, “Pfizer would stop surveillance for signs of COVID illness for all participants in the study after April 3.”

While REUTERS noted that, “It’s not clear what path Pfizer could use for FDA approval,” the April 1st article ended with the foretelling statement that:

“Updated COVID vaccines for approved groups are typically cleared based on immune response data showing how well a new formulation generated antibodies against circulating variants, similar to the agency’s approach for annual flu shots.”

Antibody Titers are Again the FDA Approval Efficacy Standard

In other words, with Dr. Marty Makary and Vinay Prasad ousted from the agency, the FDA is back to approving COVID-19 boosters for all age groups (and health-statuses) based on antibody responses (potentially not even in humans).

Below is an excerpt from one my 2022 articles:

“COVID-19 shots are genetic biological agents that to this day, remain largely untested. They were tested for only 2 months before given Emergency Use (EUA)approval for public use. That means if you take them, you become the guinea pig.” - Dr. Russel Blaylock

Dr. Vinay Prasad Took Courageous Actions in Attempting to Restore Lawful Safety Standards for Human Use of Vaccines and Biologics

It is a tragic state of affairs that most Americans believe that the previously approved COVID-19 mRNA injections and future boosters are based on bona fide clinical safety and efficacy standards for human use.

Dr. Vinay Prasad made numerous efforts to re-establish the clinical trial standards for the use of biologics and vaccines in human adults, children, and pregnancy women. Dr. Prasad was and is a courageous man who took on the corrupt biopharmaceutical industrial complex from inside the viper’s nest. I wish all the best for him and his family.

Thank you for your service Dr. Prasad.

Exodus 18:21

Select capable men from all the people—men who fear God, trustworthy men who hate dishonest gain—and appoint them as officials over thousands, hundreds, fifties and tens.

The Kingston Report. TRUTH WINS.

Ways to Support My Work

Make a on-time donation at buy me a coffee (Ko-fi)

Support the Kingston Report by becoming a free or paid subscriber.

Mail: Karen Kingston - 1700 Aviara Parkway, #130063 - Carlsbad, CA 92013